Roy Winston, Chief Medical Officer at Pacira BioSciences, Inc. (PCRX), sold 7,272 shares at $37.87 ($279K) on 2023-06-07, disclosed to the SEC on 2023-06-07.
Seasonal sale ($279k) by Chief Medical Officer — this insider has traded PCRX in June in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $38.99 | 1,779 | $69K | 24.8% |
| 2 | $38.99 | 1,779 | $69K | 24.8% |
| 3 | $37.87 | 1,857 | $70K | 25.2% |
| 4 | $37.87 | 1,857 | $70K | 25.2% |
| Total | $38.42 avg | 7,272 | $279K | 100% |
| Filing → |
| PCRX | SELL | 2022-06-08 | $1.9M | — | Filing → |
| PCRX | SELL | 2021-06-08 | $278K | — | Filing → |
| PCRX | SELL | 2021-04-02 | $3.1M | — | Filing → |